Quality of Pharmacovigilance and ADRs Reporting in Developing Countries: Status and Future Recommendations

Pharmacovigilance and the reporting of adverse drug reactions (ADRs) play a crucial role in ensuring patient safety and optimizing the use of medicines. This chapter explores the current status, achievements, challenges, and recommendations for enhancing the quality of pharmacovigilance and ADRs reporting in developing countries. It highlights the need for strengthening regulatory frameworks, increasing resources, promoting capacity building and training, fostering collaboration, utilizing technology, and integrating pharmacovigilance into healthcare systems. By implementing these recommendations, developing countries can improve the effectiveness and efficiency of pharmacovigilance, leading to enhanced patient safety and better public health outcomes.